Berr, Kristina http://orcid.org/0000-0002-3324-9617
Tizek, Linda http://orcid.org/0000-0002-2749-9791
Schielein, Maximilian C. http://orcid.org/0000-0003-3767-1337
Welcker, Martin http://orcid.org/0000-0002-1856-3085
Knitza, Johannes http://orcid.org/0000-0001-9695-0657
Kleinert, Stefan http://orcid.org/0000-0002-2588-7547
Zink, Alexander http://orcid.org/0000-0001-9313-6588
Funding for this research was provided by:
Novartis Pharma
Technische Universität München
Article History
Received: 2 November 2022
Accepted: 3 January 2023
First Online: 14 January 2023
Declarations
:
: LT received unrestricted research grants by Novartis Pharma GmbH and is currently employed by ViiV Healthcare GmbH. MCS is currently employed by Novartis Pharma GmbH.
: This study does not contain any human or animal experiments conducted by the authors.